Home - Products - Metabolic Enzyme/Protease - Retinoid Receptor - K-8012

K-8012

CAS No. 1346513-17-4

K-8012( —— )

Catalog No. M33994 CAS No. 1346513-17-4

K-8012 is a modulator of the N-terminally truncated RXRα and improves anticancer activities in an RXRα-dependent manner.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	178	Get Quote
5MG	255	Get Quote
10MG	375	Get Quote
25MG	545	Get Quote
50MG	762	Get Quote
100MG	1017	Get Quote
500MG	2043	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

K-8012
Note

Research use only, not for human use.
Brief Description

K-8012 is a modulator of the N-terminally truncated RXRα and improves anticancer activities in an RXRα-dependent manner.
Description

K-8012 is a modulator of the N-terminally truncated RXRα and improves anticancer activities in an RXRα-dependent manner.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Metabolic Enzyme/Protease
Target

Retinoid Receptor
Recptor

Retinoid Receptor | RAR/RXR?
Research Area

——
Indication

——

Chemical Information

CAS Number

1346513-17-4
Formula Weight

374.45
Molecular Formula

C23H23FN4
Purity

>98% (HPLC)
Solubility

——
SMILES

C(=C/1\C=2C(C(CCC=3NN=NN3)=C1C)=CC(F)=CC2)\C4=CC=C(C(C)C)C=C4
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

BMS493

BMS493 is an inverse agonist of the pan-retinoic acid receptor (RAR) that inhibits retinoic acid-induced differentiation, enhances the interaction of nuclear co-inhibitors with RARs, attenuates RA signaling, potentiates TPP-induced toxicity, and inhibits the increase in phospholipase A2 activity.
Bexarotene

Bexarotene is a retinoid specifically selective for retinoid X receptors, used as an oral antineoplastic agent in the treatment of cutaneous T-cell lymphoma.
PA452

PA452 is a retinoic X receptor (RXR) specific antagonist. PA452 suppresses the effect of Retinoic acid (RA) on Th1/Th2 development.

Sign In Join Free